The following articles are protected by patents in the U.S. and elsewhere. This page is intended to satisfy applicable virtual patent marking requirements of various jurisdictions, including those of the America Invents Act, and to provide notice under 35 U.S.C. § 287(a). The following list of products and patents may not be all inclusive.
US 6,864,046 B1
US 17/364,792, PCT/US2021/040017, Patent Pending
All ProteX claims of improved semen quality are made comparing collection in ProteX to collection in a standard specimen cup, and are based on published study data. Results using ProteX will vary by each patient and are affected by a number of uncontrolled factors, including and not limited to the patient’s age, diagnosis, lifestyle, diet, and genetics. Reproductive Solutions makes no guarantee of pregnancy outcomes when using ProteX. ProteX is a registered trademark of Reproductive Solutions.
Patent US 6,864,046 B1, Patent: US 17/364,792, PCT/US2021/040017 Ctrl# PTX-MMTL-20044 rev. 00
© 2024 Reproductive Solutions.
